Implications of palmitoleic acid (Palmitoleate) on glucose homeostasis, insulin resistance and diabetes

Current Drug Targets

Volumn 17, Issue , 2016, Pages

  Nunes, Everson Araújo ^a   Rafacho, Alex ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Diabetes; Glucose homeostasis; Insulin sensitivity; Obesity; Omega 7; Palmitoleic acid

Indexed keywords

ACYL COENZYME A DESATURASE; CHOLECYSTOKININ; CYCLIC AMP DEPENDENT PROTEIN KINASE; DEVAZEPIDE; EPINEPHRINE; GLUCAGON; GLUCOSE TRANSPORTER 1; GROWTH HORMONE; HYDROCORTISONE; INSULIN; INSULIN RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; PALMITOLEIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHOSPHOLIPID; PROTEIN KINASE C; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR;

CELL FUNCTION; DISEASE ASSOCIATION; ENDOPLASMIC RETICULUM STRESS; FOOD INTAKE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULINEMIA; LIPID STORAGE; LIPOTOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84991510584     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: None     Document Type: Review

References (102)

1. Misra A, Singhal N, Khurana L. Obesity, the metabolic syndrome, and type 2 diabetes in developing countries: role of dietary fats and oils. J Am Coll Nutr 2010; 29: 289S-301S.
2. Risérus U, Willett WC, Hu FB. Dietary fats and prevention of type 2 diabetes. Prog Lipid Res 2009; 48: 44-51.
3. Lancha A, Frühbeck G, Gómez-Ambrosi J. Peripheral signalling involved in energy homeostasis control. Nutr Res Rev 2012; 25: 223-48.
4. Soeters MR, Soeters PB, Schooneman MG, Houten SM, Romijn JA. Adaptive reciprocity of lipid and glucose metabolism in human short-term starvation. Am J Physiol Endocrinol Metab 2012; 303: E1397-407.
5. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444: 840-6.
6. Kellett GL, Brot-Laroche E, Mace OJ, Leturque A. Sugar absorption in the intestine: the role of GLUT2. Annu Rev Nutr 2008; 28: 35-54.
7. Huang S, Czech MP. The GLUT4 glucose transporter. Cell Metab 2007; 5: 237-52.
8. Oh KJ, Han HS, Kim MJ, Koo SH. Transcriptional regulators of hepatic gluconeogenesis. Arch Pharm Res 2013; 36: 189-200.
9. Tonelli J, Kishore P, Lee DE, Hawkins M. The regulation of glucose effectiveness: how glucose modulates its own production. Curr Opin Clin Nutr Metab Care 2005; 8: 450-6.
10. Cani PD, Geurts L, Matamoros S, Plovier H, Duparc T. Glucose metabolism: Focus on gut microbiota, the endocannabinoid system and beyond. Diabetes Metab 2014; 13: S1262-3636.
11. Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007; 132: 2131-57.
12. Matschinsky FM. Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes 1996; 45: 223-41.
13. Nesher R, Anteby E, Yedovizky M, Warwar N, Kaiser N, Cerasi E. Beta-cell protein kinases and the dynamics of the insulin response to glucose. Diabetes 2002; 51: S68-73.
14. Komatsu M, Takei M, Ishii H, Sato Y. Glucose-stimulated insulin secretion: A newer perspective. J Diabetes Investig 2013; 4:511-6.
15. Zhou YP, Grill VE. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest 1994; 93: 870-6.
16. Liu YQ, Tornheim K, Leahy JL. Shared biochemical properties of glucotoxicity and lipotoxicity in islets decrease citrate synthase activity and increase phosphofructokinase activity. Diabetes 1998; 47: 1889-93.
17. Gravena C, Mathias PC, Ashcroft SJ. Acute effects of fatty acids on insulin secretion from rat and human islets of Langerhans. J Endocrinol 2002; 173: 73-80.
18. El-Azzouny M, Evans CR, Treutelaar MK, Kennedy RT, Burant CF. Increased Glucose Metabolism and Glycerolipid Formation by Fatty Acids and GPR40 Receptor Signaling Underlies the Fatty Acid Potentiation of Insulin Secretion. J Biol Chem 2014; 289: 13575-88.
19. Vogt MC, Brüning JC. CNS insulin signaling in the control of energy homeostasis and glucose metabolism - from embryo to old age. Trends Endocrinol Metab 2013; 24: 76-84.
20. Moller DE, Yokota A, Caro JF, Flier JS. Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man. Mol Endocrinol 1989; 3: 1263-9.
21. Mosthaf L, Grako K, Dull TJ, Coussens L, Ullrich A, McClain DA. Functionally distinct insulin receptors generated by tissue-specific alternative splicing. EMBO J 1990; 9: 2409-13.
22. Cohen P. The twentieth century struggle to decipher insulin signaling. Nat Rev Mol Cell Biol 2006; 7: 867-73.
23. Wisse BE, Kim F, Schwartz MW. Physiology. An integrative view of obesity. Science 2007; 318: 928-9.
24. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-45.
25. Ng M, Fleming T, Robinson M, Thomson B, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384: 766-81.
26. Alonso-Magdalena P, Quesada I, Nadal A. Endocrine disruptors in the etiology of type 2 diabetes mellitus. Nat Rev Endocrinol 2011; 7: 346-53.
27. Janesick A, Blumberg B. Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity. Birth Defects Res C Embryo Today 2011; 93: 34-50.
28. Lillycrop KA, Burdge GC. Epigenetic changes in early life and future risk of obesity. Int J Obes 2011; 35: 72-83.
29. Virtue S, Vidal-Puig A. Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome--an allostatic perspective. Biochim Biophys Acta 2010; 1801: 338-49.
30. Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract 2014; 105: 141-50.
31. Skurk T, Alberti-Huber C, Herder C, Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 2007; 92: 1023-33.
32. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AWJr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-808.
33. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004; 145: 2273-82.
34. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005; 115: 1111-9.
35. Yang Q, Graham TE, Mody N, Preitner F, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 2005, 436(7049), 356-362.
36. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444:860-7.
37. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007; 117: 175-84.
38. Boden G. Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes. Exp Clin Endocrinol Diabetes 2003; 111: 121-4.
39. Cani PD, Amar J, Iglesias MA, Poggi M, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56: 1761-72.
40. Wood IS, de Heredia FP, Wang B, Trayhurn P. Cellular hypoxia and adipose tissue dysfunction in obesity. Proc Nutr Soc 2009; 68: 370-7.
41. Cnop M, Foufelle F, Velloso LA. Endoplasmic reticulum stress, obesity and diabetes. Trends Mol Med 2012; 18: 59-68.
42. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 2000; 106: 171-6.
43. Bournat JC, Brown CW. Mitochondrial dysfunction in obesity. Curr Opin Endocrinol Diabetes Obes 2010; 17: 446-52.
44. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87: 4-14.
45. Weir GC, Bonner-Weir S. Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 2004; 53: S16-21.
46. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993; 42:1663-72.
47. Halban PA, Polonsky KS, Bowden DW, Hawkins MA, et al. β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment. Diabetes Care 2014; 37: 1751-8.
48. Matveyenko AV, Butler PC. Relationship between beta-cell mass and diabetes onset. Diabetes Obes Metab 2008; 10: 23-31.
49. Costes S, Langen R, Gurlo T, Matveyenko AV, Butler PC. β-Cell failure in type 2 diabetes: a case of asking too much of too few? Diabetes 2013; 62: 327-35.
50. Eckel RH, Kahn SE, Ferrannini E, Goldfine AB, et al. Obesity and type 2 diabetes: what can be unified and what needs to be individualized? J Clin Endocrinol Metab 2011; 96: 1654-63.
51. Pal A, McCarthy MI. The genetics of type 2 diabetes and its clinical relevance. Clin Genet 2013; 83: 297-306.
52. Drong AW, Lindgren CM, McCarthy MI. The genetic and epigenetic basis of type 2 diabetes and obesity. Clin Pharmacol Ther 2012; 92: 707-15.
53. Thompson RF, Fazzari MJ, Niu H, Barzilai N, Simmons RA, Greally JM. Experimental intrauterine growth restriction induces alterations in DNA methylation and gene expression in pancreatic islets of rats. J Biol Chem 2010; 285: 15111-8.
54. Guay C, Regazzi R. Circulating microRNAs as novel biomarkers for diabetes mellitus. Nat Rev Endocrinol 2013; 9: 513-21.
55. Smyth S, Heron A. Diabetes and obesity: the twin epidemics. Nat Med 2006; 12: 75-80.
56. Scheen AJ. Pathophysiology of insulin secretion. Ann Endocrinol 2004; 65: 29-36.
57. Godoy-Matos AF. The role of glucagon on type 2 diabetes at a glance. Diabetol Metab Syndr 2014; 6: 91.
58. Lund A, Bagger JI, Christensen M, Knop FK, Vilsbøll T. Glucagon and type 2 diabetes: the return of the alpha cell. Curr Diab Rep 2014; 14: 555.
59. Stetten D, Schoenheimer R. The conversion of palmitic acid into stearic and palmitoleic acid in rats. J Biol Chem 1940; 133: 329-45.
60. Hodson L, Skeaff CM, Fielding BA. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res 2008; 47: 348-80.
61. Hodson L, Fielding BA. Stearoyl-CoA desaturase: rogue or innocent bystander? Prog Lipid Res 2013; 52: 15-42.
62. Poudyal H, Kumar SA, Iyer A, Waanders J, Ward LC, Brown L. Responses to oleic, linoleic and α-linolenic acids in highcarbohydrate, high-fat diet-induced metabolic syndrome in rats. J Nutr Biochem 2013; 24: 1381-92.
63. Yang B, Kallio HP. Fatty acid composition of lipids in sea buckthorn (Hippophaë rhamnoides L.) berries of different origins. J Agric Food Chem 2001; 49: 1939-47.
64. Dulf FV. Fatty acids in berry lipids of six sea buckthorn (Hippophae rhamnoides L., subspecies carpatica) cultivars grown in Romania. Chem Cent J 2012; 6: 106-118.
65. Moffat CF, McGill AS. Variability of the composition of fish oils: significance for the diet. Proc Nutr Soc 1993; 52: 441-456.
66. Mozaffarian D, de Oliveira Otto MC, Lemaitre RN, Fretts AM, et al. trans-Palmitoleic acid, other dairy fat biomarkers, and incident diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 2013; 97: 854-61.
67. Jaudszus A, Kramer R, Pfeuffer M, Roth A, et al. trans-Palmitoleic acid arises endogenously from dietary vaccenic acid. Am J Clin Nutr 2014; 99: 431-5.
68. Cao H, Gerhold K, Mayers JR, Wiest MM, et al. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 2008; 134: 933-44.
69. Maedler K, Oberholzer J, Bucher P, Spinas GA, Donath MY. Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. Diabetes 2003; 52: 726-33.
70. Dimopoulos N, Watson M, Sakamoto K, Hundal HS. Differential effects of palmitate and palmitoleate on insulin action and glucose utilization in rat L6skeletal muscle cells. Biochem J 2006; 399: 473-81.
71. Talbot NA, Wheeler-Jones CP, Cleasby ME. Palmitoleic acid prevents palmitic acid-induced macrophage activation and consequent p38 MAPK-mediated skeletal muscle insulin resistance. Mol Cell Endocrinol 2014; 393: 129-42.
72. Kadotani A, Tsuchiya Y, Hatakeyama H, Katagiri H, Kanzaki M. Different impacts of saturated and unsaturated free fatty acids on COX-2 expression in C(2)C(12) myotubes. Am J Physiol Endocrinol Metab 2009; 297: E1291-303.
73. Burns TA, Kadegowda AK, Duckett SK, Pratt SL, Jenkins TC. Palmitoleic (16:1cis-9) and cis-vaccenic (18:1 cis-11) acid alter lipogenesis in bovine adipocyte cultures. Lipids 2012; 47: 1143-53.
74. Bolsoni-Lopes A, Festuccia WT, Farias TS, et al. Palmitoleic acid (n-7) increases white adipocyte lipolysis and lipase content in a PPARα-dependent manner. Am J Physiol Endocrinol Metab 2013; 305: 1093-102.
75. Bolsoni-Lopes A, Festuccia WT, Chimin P, et al. Palmitoleic acid (n-7) increases white adipocytes GLUT4 content and glucose uptake in association with AMPK activation. Lipids Health Dis 2014;13:199-209.
76. Sauma L, Stenkula KG, Kjølhede P, Strålfors P, et al. PPARgamma response element activity in intact primary human adipocytes: effects of fatty acids. Nutrition 2006; 22: 60-8.
77. Koeberle A, Shindou H, Harayama T, Shimizu T. Palmitoleate is a mitogen, formed upon stimulation with growth factors, and converted to palmitoleoyl-phosphatidylinositol. J Biol Chem 2012; 287: 27244-54.
78. Yang ZH, Miyahara H, Hatanaka A. Chronic administration of palmitoleic acid reduces insulin resistance and hepatic lipid accumulation in KK-Ay Mice with genetic type 2 diabetes. Lipids Health Dis 2011; 10: 120.
79. Duckett SK, Volpi-Lagreca G, Alende M, Long NM. Palmitoleic acid reduces intramuscular lipid and restores insulin sensitivity in obese sheep. Diabetes Metab Syndr Obes 2014; 20: 553-63.
80. Yang ZH, Takeo J, Katayama M. Oral administration of omega-7 palmitoleic acid induces satiety and the release of appetite-related hormones in male rats. Appetite 2013; 65: 1-7.
81. Barrena HC, Schiavon FP, Cararra MA, Marques Ade C, et al. Effect of linseed oil and macadamia oil on metabolic changes induced by high-fat diet in mice. Cell Biochem Funct 2014; 32: 333-40.
82. Rajaram S, Sabaté J. Nuts, body weight and insulin resistance. Br J Nutr 2006; 96: S79-86.
83. Lehtonen HM, Järvinen R, Linderborg K, Viitanen M, et al. Postprandial hyperglycemia and insulin response are affected by sea buckthorn (Hippophaë rhamnoides ssp. turkestanica) berry and its ethanol-soluble metabolites. Eur J Clin Nutr 2010; 64: 1465-71.
84. Lee C, Liese A, Wagenknecht L, Lorenzo C, Haffner S, Hanley A. Fish consumption, insulin sensitivity and beta-cell function in the Insulin Resistance Atherosclerosis Study (IRAS). Nutr Metab Cardiovasc Dis 2013; 23: 829-35.
85. Jaceldo-Siegl K, Haddad E, Oda K, Fraser GE, Sabaté J. Tree nuts are inversely associated with metabolic syndrome and obesity: the Adventist health study-2. PLoS One 2014; 9: e85133.
86. Hirahatake KM, Slavin JL, Maki KC, Adams SH. Associations between dairy foods, diabetes, and metabolic health: potential mechanisms and future directions. Metabolism 2014; 63: 618-27.
87. Mozaffarian D, Cao H, King IB, Lemaitre RN, et al. Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes. Am J Clin Nutr 2010; 92: 1350-8.
88. Mahendran Y, Ågren J, Uusitupa M, Cederberg H, et al. Association of erythrocyte membrane fatty acids with changes in glycemia and risk of type 2 diabetes. Am J Clin Nutr 2014; 99: 79-85.
89. Lankinen MA, Stančáková A, Uusitupa M, Ågren J, Pihlajamäki J, Kuusisto J, Schwab U, Laakso M. Plasma fatty acids as predictors of glycaemia and type 2 diabetes. Diabetologia 2015; 58: 2533-44.
90. Stefan N, Kantartzis K, Celebi N, Staiger H, et al. Circulating palmitoleate strongly and independently predicts insulin sensitivity in humans. Diabetes Care 2010; 33: 405-7.
91. Mozaffarian D, Cao H, King IB, Lemaitre RN, et al. Transpalmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study. Ann Intern Med 2010; 153: 790-9.
92. Vessby B, Ahrén B, Warensjö E, Lindgärde F. Plasma lipid fatty acid composition, desaturase activities and insulin sensitivity in Amerindian women. Nutr Metab Cardiovasc Dis. 2012; 22: 176-81.
93. Kratz M, Marcovina S, Nelson JE, Yeh MM, et al. Dairy fat intake is associated with glucose tolerance, hepatic and systemic insulin sensitivity, and liver fat but not β-cell function in humans. Am J Clin Nutr 2014; 99: 1385-96.
94. Yakoob MY, Shi P, Hu FB, et al. Circulating biomarkers of dairy fat and incident type 2 diabetes in two U.S. prospective cohort studies. Circulation 2014; 129. (Abstract)
95. Wang Q, Imamura F, Ma W, et al. Circulating and dietary transfatty acids and incident type-2 diabetes mellitus in older adults: The cardiovascular health study. Circulation 2014; 129: 1099-107.
96. de Souza RJ, Mente A, Maroleanu A, et al. Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and metaanalysis of observational studies. BMJ 2015; 11: h3978.
97. Lee JJ, Lambert JE, Hovhannisyan Y, et al. Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis. Am J Clin Nutr 2015; 101: 34-43.
98. Volk BM, Kunces LJ, Freidenreich DJ, et al. Effects of step-wise increases in dietary carbohydrate on circulating saturated Fatty acids and palmitoleic acid in adults with metabolic syndrome. PLoS One 2014; 201: e113605.
99. Paillard F, Catheline D, Duff FL, et al. Plasma palmitoleic acid, a product of stearoyl-coA desaturase activity, is an independent marker of triglyceridemia and abdominal adiposity. Nutr Metab Cardiovasc Dis 2008; 8: 436-40.
100. Gong J, Campos H, McGarvey S, Wu Z, Goldberg R, Baylin A. Adipose tissue palmitoleic acid and obesity in humans: does it behave as a lipokine? Am J Clin Nutr 2011; 93: 186-91.
101. Pinnick KE, Neville MJ, Fielding BA, Frayn KN, Karpe F, Hodson L. Gluteofemoral adipose tissue plays a major role in production of the lipokine palmitoleate in humans. Diabetes 2012; 61: 1399-403.
102. Chan KL, Pillon NJ, Sivaloganathan DM, et al. Palmitoleate Reverses High Fat-induced Proinflammatory Macrophage Polarization via AMP-activated Protein Kinase (AMPK). J Biol Chem 2015; 3: 16979-88.